Companies sponsors |
Pfizer (elranatamab) |
Others |
Department of Health and Social Care |
|
NHS England |
Patient carer groups |
Myeloma UK |
Professional groups |
Association of Cancer Physicians |
|
Cancer Research UK |
|
Royal College of Radiologists |
|
Royal College of Physicians |
|
UK Myeloma Society |
Assessment group |
Aberdeen HTA Group |
Associated public health groups |
Public Health Wales |
|
UK Health Security Agency |
Comparator companies |
Bristol Myers Squibb Pharmaceuticals (lenalidomide, pomalidomide) (confidentiality agreement signed, participating) |
|
GlaxoSmithKline (belantamab mafodotin) (confidentiality agreement signed, participating) |
|
Janssen-Cilag (bortezomib, daratumumab) (confidentiality agreement signed, participating) |
|
Takeda (ixazomib) (confidentiality agreement signed, participating) |
|
Accord Healthcare (bortezomib, lenalidomide) (confidentiality agreement not signed, not participating) |
|
Aspire Pharma (bortezomib) (confidentiality agreement not signed, not participating) |
|
Cipla EU (lenalidomide) (confidentiality agreement not signed, not participating) |
|
Dr Reddy's Laboratories (bortezomib) (confidentiality agreement not signed, not participating) |
|
Medac GmbH (bortezomib) (confidentiality agreement not signed, not participating) |
|
MSN Laboratories Europe (bortezomib) (confidentiality agreement not signed, not participating) |
|
Mylan (lenalidomide) (confidentiality agreement not signed, not participating) |
|
Piramal Critical Care (lenalidomide) |
|
Ranbaxy (bortezomib) (confidentiality agreement not signed, not participating) |
|
Sandoz (bortezomib, cyclophosphamide) (confidentiality agreement not signed, not participating) |
|
Secura Bio (panobinostat) (confidentiality agreement not signed, not participating) |
|
Teva UK (lenalidomide) (confidentiality agreement not signed, not participating) |
|
Thornton & Ross (bortezomib, lenalidomide) (confidentiality agreement not signed, not participating) |
|
Tillomed Laboratories (bortezomib) (confidentiality agreement not signed, not participating) |
|
Zentiva (bortezomib, lenalidomide) (confidentiality agreement not signed, not participating) |
General commentators |
All Wales Therapeutics and Toxicology Centre |
|
British National Formulary |
|
Department of Health, Social Services and Public Safety for Northern Ireland |
|
Healthcare Improvement Scotland |
|
Medicines and Healthcare products Regulatory Agency |
|
Scottish Medicines Consortium |
|
Welsh Government |
|
Welsh Health Specialised Services Committee |
Relevant research groups |
Institute of Cancer Research |
|
National Institute for Health Research |